| 1 | HJ-4, a novel piperine derivative, inhibits tumor growth and angiogenesis via p53 activation and oncogenic pathway inhibition in colorectal cancer models. (Zhang L, Liu S, Wang D, Zhang X, Hu Z, Zou X, Li X, Wang X, Xu D, Liu W, Liu B) Sci Rep 2025 Sep 29;15(1):33541 |
| 1 | Real-time 3D confirmation of complete ablation with margins as a local cure for colorectal liver metastases: the ACCLAIM trial. (Sofocleous CT, Callstrom MR, Petre EN, Gonen M, Rilling WS, Ahmed M, Kelekis A, Soulen MC, Pereira P, Crocetti L, Dupuy DE, Solbiati L) Trials 2025 Sep 26;26(1):360 1 Citation |
| 2 | Of Endpoints and Equipoise: Reforming Clinical Trials in Colorectal Polyp Resection. (Smith ZL, Forbes N, Madhavan S, Pohl H, Schauer JM, Steinbrück I, von Renteln D) Curr Gastroenterol Rep 2025 Sep 18;27(1):62 1 Citation |
| 1 | Phenome-wide association study identifies multiple traits associated with a polygenic risk score for colorectal cancer. (Rosenthal EA, Wei WQ, Luo Y, Namjou-Khales B, Schaid DJ, Esplin ED, Lape M, Kottyan L, Pacheco JA, Weng C, Gordon AS, Kullo IJ, Crosslin DR, Grady WM, Hsu L, Peters U, Jarvik GP) Hum Genomics 2025 Jul 09;19(1):77 2 Citations |
| 1 | Case Report WIN-MTB-2023001 WIN International Molecular Tumor Board A 62-year-old male with metastatic colorectal cancer with 5 prior lines of treatment. (Hernando-Calvo A, Kurzrock R, Gonzalez NS, Magidi S, Bresson C, Wunder F, Pretelli G, Casado AM, El-Deiry WS) Oncotarget 2025 Jun 17;16:456-466 1 Citation |
| 1 | A novel piperine derivative HJJ_3_5 inhibits colorectal cancer progression by modulating EMT signaling pathways. (Cheng W, Liu S, He J, Li H, Liu X, Hu Z, Wang X, Wu Z, Xu G, Liu W, Liu B) Biochem Biophys Res Commun 2025 Feb 16;749:151323 5 Citations |
| 1 | Association of clonal hematopoiesis and mosaic chromosomal alterations with solid malignancy incidence and mortality. (Desai P, Zhou Y, Grenet J, Handelman SK, Crispino CM, Tarbay LN, Whitsel EA, Roboz G, Barac A, Honigberg M, Bick A, Anderson G, Wactawski-Wende J, Jakubek Swartzlander YA, Bacon J, Wong J, Ma X, Scheet P, Li Z, Kasi P, Prentice R, Auer P, Manson JE, Reiner A, Simon M) Cancer 2024 Nov 15;130(22):3879-3887 8 Citations |
| 1 | Clinical and biological landscape of constitutional mismatch-repair deficiency syndrome: an International Replication Repair Deficiency Consortium cohort study. (Ercan AB, Aronson M, Fernandez NR, Chang Y, Levine A, Liu ZA, Negm L, Edwards M, Bianchi V, Stengs L, Chung J, Al-Battashi A, Reschke A, Lion A, Ahmad A, Lassaletta A, Reddy AT, Al-Darraji AF, Shah AC, Van Damme A, Bendel A, Rashid A, Margol AS, Kelly BL, Pencheva B, Heald B, Lemieux-Anglin B, Crooks B, Koschmann C, Gilpin C, Porter CC, Gass D, Samuel D, Ziegler DS, Blumenthal DT, Kuo DJ, Hamideh D, Basel D, Khuong-Quang DA, Stearns D, Opocher E, Carceller F, Baris Feldman H, Toledano H, Winer I, Scheers I, Fedorakova I, Su JM, Vengoechea J, Sterba J, Knipstein J, Hansford JR, Gonzales-Santos JR, Bhatia K, Bielamowicz KJ, Minhas K, Nichols KE, Cole KA, Penney L, Hjort MA, Sabel M, Gil-da-Costa MJ, Murray MJ, Miller M, Blundell ML, Massimino M, Al-Hussaini M, Al-Jadiry MF, Comito MA, Osborn M, Link MP, Zapotocky M, Ghalibafian M, Shaheen N, Mushtaq N, Waespe N, Hijiya N, Fuentes-Bolanos N, Ahmad O, Chamdine O, Roy P, Pichurin PN, Nyman P, Pearlman R, Auer RC, Sukumaran RK, Kebudi R, Dvir R, Raphael R, Elhasid R, McGee RB, Chami R, Noss R, Tanaka R, Raskin S, Sen S, Lindhorst S, Perreault S, Caspi S, Riaz S, Constantini S, Albert S, Chaleff S, Bielack S, Chiaravalli S, Cramer SL, Roy S, Cahn S, Penna S, Hamid SA, Ghafoor T, Imam U, Larouche V, Magimairajan Issai V, Foulkes WD, Lee YY, Nathan PC, Maruvka YE, Greer MC, Durno C, Shlien A, Ertl-Wagner B, Villani A, Malkin D, Hawkins C, Bouffet E, Das A, Tabori U) Lancet Oncol 2024 May;25(5):668-682 47 Citations |
| 1 | Preoperative CA 19-9 Predicts Disease Progression in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: An Analysis from the US HIPEC Collaborative. (Fackche NT, Schmocker RK, Nudotor R, Kubi B, Cloyd JM, Grotz TE, Fournier KF, Dineen SP, Veerapong J, Baumgartner JM, Clarke CN, Patel SH, Wilson GC, Lambert LA, Pokrzywa C, Abbott DE, Lee B, Staley CA, Zaidi MY, Johnston FM, Greer JB) Ann Surg Oncol 2024 May;31(5):3314-3324 2 Citations |
| 1 | Liver transplantation as an alternative for the treatment of non-resectable liver colorectal cancer: Advancing the therapeutic algorithm. (Rawashdeh B, Bell R, Hakeem A, Prasad R) Hepatobiliary Pancreat Dis Int 2024 Apr;23(2):154-159 1 Citation |
| 1 | Cationic micelle delivery of a multi-epitope vaccine candidate derived from tumor-associated antigens, causing regression in established CT26 colorectal tumors in mice. (Sabzehei F, Taromchi AH, Ramazani A, Nedaei K, Feizi A, Arsang-Jang S, Danafar H) J Biomed Mater Res A 2024 May;112(5):733-742 3 Citations |
| 1 | Evaluation of the Rothman Index in Predicting Readmission after Colorectal Resection. (Peterson KJ, O'Donnell CM, Eastwood DC, Szabo A, Hu KY, Ridolfi TJ, Ludwig KA, Peterson CY) Am J Med Qual 2023 Nov 01;38(6):287-293 2 Citations |
| 1 | PD-1 and PD-L1 inhibitors in cold colorectal cancer: challenges and strategies. (Lin KX, Istl AC, Quan D, Skaro A, Tang E, Zheng X) Cancer Immunol Immunother 2023 Dec;72(12):3875-3893 105 Citations |
| 1 | Neighborhood-Level Socioeconomic Disadvantage Predicts Outcomes in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Malignancy. (Winicki NM, Radomski SN, Florissi IS, Cloyd JM, Gutta G, Grotz TE, Scally CP, Fournier KF, Dineen SP, Powers BD, Veerapong J, Baumgartner JM, Clarke CN, Kothari AN, Maduekwe UN, Patel SH, Wilson GC, Schwartz P, Varley PR, Raoof M, Lee B, Malik I, Johnston FM, Greer JB) Ann Surg Oncol 2023 Nov;30(12):7840-7847 7 Citations |
| 1 | Multi-Institutional Review From the Pediatric Colorectal and Pelvic Learning Consortium of Minor Spinal Cord Dysraphism in the Setting of Anorectal Malformations: Diagnosis, Treatment, and Outcomes. (Garvey EM, Fuller M, Frischer J, Calkins CM, Rentea RM, Ralls M, Wood R, Rollins MD, Avansino J, Reeder RW, Durham MM, Pediatric Colorectal and Pelvic Learning Consortium (PCPLC)) J Pediatr Surg 2023 Aug;58(8):1582-1587 |
| 2 | Pathologic, immunologic, and clinical analysis of the microsatellite instability phenotype in endometrial carcinoma. (Mackinnon AC Jr, Johnson CM, Robin A, Christiansen L, Hanbazazh M, Summey RM, Chandrashaker D, Harada S, Bradley WH) Hum Pathol 2023 Sep;139:80-90 3 Citations |
| 1 | Editorial Comment: Multichannel Outreach for Lung Cancer Screening Adoption. (Bergmann LL) AJR Am J Roentgenol 2023 Aug;221(2):272 |
| 1 | Chemotherapy-induced peripheral neuropathy in the detroit research on cancer survivors (ROCS) cohort. (Sreeram K, Seaton R, Greenwald MK, Kamgar M, Assad H, Baird T, Schwartz AG, Ruterbusch J, Simon MS) Cancer Causes Control 2023 May;34(5):459-468 5 Citations |
| 2 | Dual blockage of both PD-L1 and CD47 enhances the therapeutic effect of oxaliplatin and FOLFOX in CT-26 mice tumor model. (Alimohammadi R, Mahmoodi Chalbatani G, Alimohammadi M, Ghaffari-Nazari H, Rahimi A, Mortaz E, Mossafa N, Boon L, Jalali SA) Sci Rep 2023 Feb 11;13(1):2472 17 Citations |
| 1 | Tissue Displacement Versus Two Primary Colorectal Carcinomas? A Case Report on the Utility of Comparative Sequencing. (Hong ES, Messersmith WA, Hammad H, Cornish TC, Aisner DL) JCO Precis Oncol 2022 Oct;6:e2200252 |
| 1 | Reconsideration of indications for third hepatectomy for colorectal liver metastases. (Kimura J, Sui K, Murokawa T, Tabuchi M, Sakamoto S, Iwata J, Iiyama T, Okabayashi T) J Surg Oncol 2022 Dec;126(7):1232-1241 3 Citations |
| 1 | Does presence of a VACTERL anomaly predict an associated gynecologic anomaly in females with anorectal malformations?: A Pediatric Colorectal and Pelvic Learning Consortium Study. (Ahmad H, Wood RJ, Avansino JR, Calkins CM, Dickie BH, Durham MM, Frischer J, Fuller M, Ralls M, Reeder RW, Rentea RM, Rollins MD, Saadai P, Oelschlager AEA, Breech LL, Hewitt GD, Kluivers K, van Leeuwen KD, McCracken KA) J Pediatr Surg 2023 Mar;58(3):471-477 10 Citations |
| 1 | Blockade of interleukin 10 potentiates antitumour immune function in human colorectal cancer liver metastases. (Sullivan KM, Jiang X, Guha P, Lausted C, Carter JA, Hsu C, Labadie KP, Kohli K, Kenerson HL, Daniel SK, Yan X, Meng C, Abbasi A, Chan M, Seo YD, Park JO, Crispe IN, Yeung RS, Kim TS, Gujral TS, Tian Q, Katz SC, Pillarisetty VG) Gut 2023 Feb;72(2):325-337 112 Citations |
| 1 | Another Signal from DEBIRI. (Soulen MC, White SB) Ann Surg Oncol 2022 Sep;29(9):5357-5358 |
| 1 | The presence of a neurodiverse disorder is associated with increased use of antegrade enema therapy in children with severe constipation: A study from the Pediatric Colorectal and Pelvic Learning Consortium (PCPLC). (Short SS, Reeder RW, Lewis KE, Dickie B, Grabowski J, Sepuha T, Durham MM, Frischer J, Badillo A, Calkins CM, Rentea RM, Ralls M, Wood RJ, Fuller MK, van Leeuwen K, Avansino JR, Austin K, Rollins MD) J Pediatr Surg 2022 Aug;57(8):1676-1680 5 Citations |
| 2 | Palliative Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis: Is It Safe and Effective? (Strong EA, Livingston A, Gracz M, Peltier W, Tsai S, Christians K, Gamblin TC, Kersting K, Clarke CN) J Surg Res 2022 Oct;278:31-38 3 Citations |
| 1 | Outcomes of Mixed Pathologic Response in Patients with Multiple Colorectal Liver Metastases Treated with Neoadjuvant Chemotherapy and Liver Resection. (Mason MC, Krasnodebski M, Hester CA, Kothari AN, Barker C, Nishioka Y, Chiang YJ, Newhook TE, Tzeng CD, Chun YS, Vauthey JN, Tran Cao HS) Ann Surg Oncol 2022 Aug;29(8):5156-5164 8 Citations |
| 1 | Precision medicine-based therapies in advanced colorectal cancer: The University of California San Diego Molecular Tumor Board experience. (Louie BH, Kato S, Kim KH, Lim HJ, Lee S, Okamura R, Fanta PT, Kurzrock R) Mol Oncol 2022 Jul;16(13):2575-2584 13 Citations |
| 1 | Sequencing of Argonaute-bound microRNA/mRNA hybrids reveals regulation of the unfolded protein response by microRNA-320a. (Fields CJ, Li L, Hiers NM, Li T, Sheng P, Huda T, Shan J, Gay L, Gu T, Bian J, Kilberg MS, Renne R, Xie M) PLoS Genet 2021 Dec;17(12):e1009934 15 Citations |
| 1 | Identification of RAS mutant biomarkers for EGFR inhibitor sensitivity using a systems biochemical approach. (McFall T, Stites EC) Cell Rep 2021 Dec 14;37(11):110096 16 Citations |
| 1 | PLEKHA7 signaling is necessary for the growth of mutant KRAS driven colorectal cancer. (Jeung HC, Puentes R, Aleshin A, Indarte M, Correa RG, Bankston LA, Layng FIAL, Ahmed Z, Wistuba I, Yao Y, Duenas DG, Zhang S, Meuillet EJ, Marassi F, Liddington RC, Kirkpatrick L, Powis G) Exp Cell Res 2021 Dec 15;409(2):112930 3 Citations |
| 1 | Disparities in the Management of Peritoneal Surface Malignancies. (Marulanda K, Maduekwe UN) Surg Oncol Clin N Am 2022 Jan;31(1):29-41 4 Citations |
| 1 | Aberrant Expression and Subcellular Localization of ECT2 Drives Colorectal Cancer Progression and Growth. (Cook DR, Kang M, Martin TD, Galanko JA, Loeza GH, Trembath DG, Justilien V, Pickering KA, Vincent DF, Jarosch A, Jurmeister P, Waters AM, Hibshman PS, Campbell AD, Ford CA, Keku TO, Yeh JJ, Lee MS, Cox AD, Fields AP, Sandler RS, Sansom OJ, Sers C, Schaefer A, Der CJ) Cancer Res 2022 Jan 01;82(1):90-104 28 Citations |
| 1 | Escherichia coli and Colorectal Cancer: Unfolding the Enigmatic Relationship. (Nouri R, Hasani A, Shirazi KM, Alivand MR, Sepehri B, Sotoodeh S, Hemmati F, Rezaee MA) Curr Pharm Biotechnol 2022;23(10):1257-1268 30 Citations |
| 1 | Perioperative and long-term functional outcomes of neonatal versus delayed primary endorectal pull-through for children with Hirschsprung disease: A pediatric colorectal and pelvic learning consortium study. (Kastenberg ZJ, Taylor MA, Durham MM, Calkins CM, Rentea RM, Wood RJ, Avansino JR, Levitt MA, van Leeuwen KD, Lewis KE, Reeder RW, Rollins MD) J Pediatr Surg 2021 Aug;56(8):1465-1469 18 Citations |
| 1 | Survival Benefit for Individuals With Constitutional Mismatch Repair Deficiency Undergoing Surveillance. (Durno C, Ercan AB, Bianchi V, Edwards M, Aronson M, Galati M, Atenafu EG, Abebe-Campino G, Al-Battashi A, Alharbi M, Azad VF, Baris HN, Basel D, Bedgood R, Bendel A, Ben-Shachar S, Blumenthal DT, Blundell M, Bornhorst M, Bronsema A, Cairney E, Rhode S, Caspi S, Chamdin A, Chiaravalli S, Constantini S, Crooks B, Das A, Dvir R, Farah R, Foulkes WD, Frenkel Z, Gallinger B, Gardner S, Gass D, Ghalibafian M, Gilpin C, Goldberg Y, Goudie C, Hamid SA, Hampel H, Hansford JR, Harlos C, Hijiya N, Hsu S, Kamihara J, Kebudi R, Knipstein J, Koschmann C, Kratz C, Larouche V, Lassaletta A, Lindhorst S, Ling SC, Link MP, Loret De Mola R, Luiten R, Lurye M, Maciaszek JL, MagimairajanIssai V, Maher OM, Massimino M, McGee RB, Mushtaq N, Mason G, Newmark M, Nicholas G, Nichols KE, Nicolaides T, Opocher E, Osborn M, Oshrine B, Pearlman R, Pettee D, Rapp J, Rashid M, Reddy A, Reichman L, Remke M, Robbins G, Roy S, Sabel M, Samuel D, Scheers I, Schneider KW, Sen S, Stearns D, Sumerauer D, Swallow C, Taylor L, Thomas G, Toledano H, Tomboc P, Van Damme A, Winer I, Yalon M, Yen LY, Zapotocky M, Zelcer S, Ziegler DS, Zimmermann S, Hawkins C, Malkin D, Bouffet E, Villani A, Tabori U) J Clin Oncol 2021 Sep 01;39(25):2779-2790 85 Citations |
| 1 | Cold versus hot endoscopic mucosal resection for large sessile colon polyps: a cost-effectiveness analysis. (Mehta D, Loutfy AH, Kushnir VM, Faulx AL, Smith ZL) Endoscopy 2022 Apr;54(4):367-375 20 Citations |
| 1 | Prognostic and Therapeutic Implications of Tumor Biology, Including Gene Alterations, in Colorectal Liver Metastases. (Nishioka Y, Kawaguchi Y, Kothari AN, Odisio BC, Vauthey JN) J Gastrointest Surg 2021 Jun;25(6):1591-1600 6 Citations |
| 1 | Black Raspberries Suppress Colorectal Cancer by Enhancing Smad4 Expression in Colonic Epithelium and Natural Killer Cells. (Huang YW, Lin CW, Pan P, Shan T, Echeveste CE, Mo YY, Wang HT, Aldakkak M, Tsai S, Oshima K, Yearsley M, Xiao J, Cao H, Sun C, Du M, Bai W, Yu J, Wang LS) Front Immunol 2020;11:570683 20 Citations |
| 1 | Two-Stage Hepatectomy for Bilateral Colorectal Liver Metastases: A Multi-institutional Analysis. (Chavez MI, Gholami S, Kim BJ, Margonis GA, Ethun CG, Tsai S, Christians KK, Clarke C, Mogal H, Maithel SK, Pawlik TM, D'Angelica MI, Aloia TA, Eastwood D, Gamblin TC) Ann Surg Oncol 2021 Mar;28(3):1457-1465 25 Citations |
| 1 | Discernment between candidate mechanisms for KRAS G13D colorectal cancer sensitivity to EGFR inhibitors. (McFall T, Schomburg NK, Rossman KL, Stites EC) Cell Commun Signal 2020 Nov 05;18(1):179 13 Citations |
| 1 | Colorectal Dysplasia and Cancer in Pediatric-Onset Ulcerative Colitis Associated With Primary Sclerosing Cholangitis. (El-Matary W, Guthery SL, Amir AZ, DiGuglielmo M, Draijer LG, Furuya KN, Gupta N, Hochberg JT, Horslen S, Kerkar N, Koot BGP, Laborda TJ, Loomes KM, Mack C, Martinez M, Miethke A, Miloh T, Mogul D, Mohammed S, Moroz S, Ovchinsky N, Perito ER, Rao G, Ricciuto A, Sathya P, Schwarz KB, Shah U, Singh R, Soufi N, Valentino PL, Zizzo A, Deneau MR) Clin Gastroenterol Hepatol 2021 May;19(5):1067-1070.e2 23 Citations |
| 1 | The Chicago Consensus on Peritoneal Surface Malignancies: Management of Colorectal Metastases. (Chicago Consensus Working Group) Ann Surg Oncol 2020 Jun;27(6):1761-1767 52 Citations |
| 1 | The Chicago Consensus on peritoneal surface malignancies: Management of colorectal metastases. (Chicago Consensus Working Group) Cancer 2020 Jun 01;126(11):2534-2540 35 Citations |
| 1 | What is the Optimal Preoperative Imaging Modality for Assessing Peritoneal Cancer Index? An Analysis From the United States HIPEC Collaborative. (Lee RM, Zaidi MY, Gamboa AC, Speegle S, Kimbrough CW, Cloyd JM, Leiting JL, Grotz TE, Lee AJ, Fournier KF, Powers BD, Dineen SP, Baumgartner J, Veerapong J, Clarke CN, Sussman JJ, Patel S, Hendrix RJ, Lambert LA, Vande Walle KA, Abbott DE, LaRocca CJ, Raoof M, Fackche N, Johnston FM, Staley CA, Maithel SK, Russell MC) Clin Colorectal Cancer 2020 Mar;19(1):e1-e7 21 Citations |
| 1 | Binimetinib, encorafenib and cetuximab (BEACON Trial) combination therapy for patients with BRAF V600E-mutant metastatic colorectal cancer. (Shahjehan F, Kamatham S, Chandrasekharan C, Kasi PM) Drugs Today (Barc) 2019 Nov;55(11):683-693 11 Citations |
| 1 | Barriers and Facilitators of Colorectal Cancer Screening Among a Hispanic Community in Michigan. (Gonzalez JJ, Wahab A, Samalik J, Ramirez E, Saint-Phard T, Gonzalez E, Adekolujo OS) J Racial Ethn Health Disparities 2020 Feb;7(1):137-143 11 Citations |
| 1 | A systems mechanism for KRAS mutant allele-specific responses to targeted therapy. (McFall T, Diedrich JK, Mengistu M, Littlechild SL, Paskvan KV, Sisk-Hackworth L, Moresco JJ, Shaw AS, Stites EC) Sci Signal 2019 Sep 24;12(600) 49 Citations |
| 1 | Feasibility of Integrating Panel-Based Pharmacogenomics Testing for Chemotherapy and Supportive Care in Patients With Colorectal Cancer. (Kasi PM, Koep T, Schnettler E, Shahjehan F, Kamatham V, Baldeo C, Hughes CL) Technol Cancer Res Treat 2019 Jan 01;18:1533033819873924 13 Citations |
| 1 | Genomic Profiling of Blood-Derived Circulating Tumor DNA from Patients with Colorectal Cancer: Implications for Response and Resistance to Targeted Therapeutics. (Choi IS, Kato S, Fanta PT, Leichman L, Okamura R, Raymond VM, Lanman RB, Lippman SM, Kurzrock R) Mol Cancer Ther 2019 Oct;18(10):1852-1862 20 Citations |
| 1 | 3-Arylindanones and related compounds as antiproliferative agents against colorectal cancer. (Srivastava A, Ravi K, Fatima K, Maheshwari M, Ashraf R, Hasanain M, Yadav P, Iqbal H, Kumar Y, Luqman S, Chanda D, Khan F, Shanker K, Sarkar J, Negi AS) Chem Biol Drug Des 2019 Sep;94(3):1694-1705 4 Citations |
| 1 | Synergistic antitumor effect of anti-PD-L1 combined with oxaliplatin on a mouse tumor model. (Golchin S, Alimohammadi R, Rostami Nejad M, Jalali SA) J Cell Physiol 2019 Nov;234(11):19866-19874 31 Citations |
| 2 | RAS Mutation Status Confers Prognostic Relevance in Patients Treated With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer. (Morgan Z, Chow BE, Strong EA, Tsai S, Christians K, Mogal H, Gamblin TC, Clarke CN) J Surg Res 2019 Aug;240:130-135 17 Citations |
| 1 | Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study. (Meric-Bernstam F, Hurwitz H, Raghav KPS, McWilliams RR, Fakih M, VanderWalde A, Swanton C, Kurzrock R, Burris H, Sweeney C, Bose R, Spigel DR, Beattie MS, Blotner S, Stone A, Schulze K, Cuchelkar V, Hainsworth J) Lancet Oncol 2019 Apr;20(4):518-530 491 Citations |
| 1 | Genetic variant predictors of gene expression provide new insight into risk of colorectal cancer. (Bien SA, Su YR, Conti DV, Harrison TA, Qu C, Guo X, Lu Y, Albanes D, Auer PL, Banbury BL, Berndt SI, Bézieau S, Brenner H, Buchanan DD, Caan BJ, Campbell PT, Carlson CS, Chan AT, Chang-Claude J, Chen S, Connolly CM, Easton DF, Feskens EJM, Gallinger S, Giles GG, Gunter MJ, Hampe J, Huyghe JR, Hoffmeister M, Hudson TJ, Jacobs EJ, Jenkins MA, Kampman E, Kang HM, Kühn T, Küry S, Lejbkowicz F, Le Marchand L, Milne RL, Li L, Li CI, Lindblom A, Lindor NM, Martín V, McNeil CE, Melas M, Moreno V, Newcomb PA, Offit K, Pharaoh PDP, Potter JD, Qu C, Riboli E, Rennert G, Sala N, Schafmayer C, Scacheri PC, Schmit SL, Severi G, Slattery ML, Smith JD, Trichopoulou A, Tumino R, Ulrich CM, van Duijnhoven FJB, Van Guelpen B, Weinstein SJ, White E, Wolk A, Woods MO, Wu AH, Abecasis GR, Casey G, Nickerson DA, Gruber SB, Hsu L, Zheng W, Peters U) Hum Genet 2019 Apr;138(4):307-326 41 Citations |
| 1 | MTORC1/2 Inhibition as a Therapeutic Strategy for PIK3CA Mutant Cancers. (Fricke SL, Payne SN, Favreau PF, Kratz JD, Pasch CA, Foley TM, Yueh AE, Van De Hey DR, Depke MG, Korkos DP, Sha GC, DeStefanis RA, Clipson L, Burkard ME, Lemmon KK, Parsons BM, Kenny PA, Matkowskyj KA, Newton MA, Skala MC, Deming DA) Mol Cancer Ther 2019 Feb;18(2):346-355 32 Citations |
| 2 | Differential relationship between colorectal cancer and diabetes in a nationally representative sample of adults. (Restifo D, Williams JS, Garacci E, Walker RJ, Ozieh MN, Egede LE) J Diabetes Complications 2018 Sep;32(9):819-823 8 Citations |
| 1 | Effect of Primary Tumor Side on Survival Outcomes in Untreated Patients With Metastatic Colorectal Cancer When Selective Internal Radiation Therapy Is Added to Chemotherapy: Combined Analysis of Two Randomized Controlled Studies. (Gibbs P, Heinemann V, Sharma NK, Taieb J, Ricke J, Peeters M, Findlay M, Robinson B, Jackson C, Strickland A, Gebski V, Van Buskirk M, Zhao H, van Hazel G, SIRFLOX and FOXFIRE Global Trial Investigators) Clin Colorectal Cancer 2018 Dec;17(4):e617-e629 63 Citations |
| 3 | Vascular Interventional Radiology-Guided Photothermal Therapy of Colorectal Cancer Liver Metastasis with Theranostic Gold Nanorods. (Parchur AK, Sharma G, Jagtap JM, Gogineni VR, LaViolette PS, Flister MJ, White SB, Joshi A) ACS Nano 2018 Jul 24;12(7):6597-6611 117 Citations |
| 1 | Screening Women Aged 50-59 for CRC Using Fecal Occult Blood Test Produces Outcomes Similar to Men Undergoing Screening Colonoscopy. (Mooers HM, Holub JL, Lieberman DA) Dig Dis Sci 2018 Oct;63(10):2780-2785 |
| 1 | Safety and efficacy of synchronous robotic surgery for colorectal cancer with liver metastases. (Dwyer RH, Scheidt MJ, Marshall JS, Tsoraides SS) J Robot Surg 2018 Dec;12(4):603-606 39 Citations |
| 1 | NKG2D Immunoligand rG7S-MICA Enhances NK Cell-mediated Immunosurveillance in Colorectal Carcinoma. (Wang T, Sun F, Wang Y, Jiang J, Pan M, Yuan M, Zhang H, Du X, Hezam K, Song K, Wang M, Zhang J) J Immunother 2018 Apr;41(3):109-117 16 Citations |
| 4 | Elevated Venous Thromboembolism Risk Following Colectomy for IBD Is Equal to Those for Colorectal Cancer for Ninety Days After Surgery. (Ali F, Al-Kindi SG, Blank JJ, Peterson CY, Ludwig KA, Ridolfi TJ) Dis Colon Rectum 2018 Mar;61(3):375-381 56 Citations |
| 1 | The timing of liver resection in patients with colorectal cancer and synchronous liver metastases: a population-based study of current practice and survival. (Vallance AE, van der Meulen J, Kuryba A, Charman SC, Botterill ID, Prasad KR, Hill J, Jayne DG, Walker K) Colorectal Dis 2018 Jun;20(6):486-495 41 Citations |
| 1 | Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors. (Krishnamurthy N, Kurzrock R) Cancer Treat Rev 2018 Jan;62:50-60 895 Citations |
| 1 | Enrichment of colorectal cancer associations in functional regions: Insight for using epigenomics data in the analysis of whole genome sequence-imputed GWAS data. (Bien SA, Auer PL, Harrison TA, Qu C, Connolly CM, Greenside PG, Chen S, Berndt SI, Bézieau S, Kang HM, Huyghe J, Brenner H, Casey G, Chan AT, Hopper JL, Banbury BL, Chang-Claude J, Chanock SJ, Haile RW, Hoffmeister M, Fuchsberger C, Jenkins MA, Leal SM, Lemire M, Newcomb PA, Gallinger S, Potter JD, Schoen RE, Slattery ML, Smith JD, Le Marchand L, White E, Zanke BW, Abeçasis GR, Carlson CS, Peters U, Nickerson DA, Kundaje A, Hsu L, GECCO and CCFR) PLoS One 2017;12(11):e0186518 8 Citations |
| 1 | Proteomic Features of Colorectal Cancer Identify Tumor Subtypes Independent of Oncogenic Mutations and Independently Predict Relapse-Free Survival. (Clarke CN, Lee MS, Wei W, Manyam G, Jiang ZQ, Lu Y, Morris J, Broom B, Menter D, Vilar-Sanchez E, Raghav K, Eng C, Chang GJ, Simon I, Bernards R, Overman M, Mills GB, Maru D, Kopetz S) Ann Surg Oncol 2017 Dec;24(13):4051-4058 29 Citations |
| 1 | First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials. (Wasan HS, Gibbs P, Sharma NK, Taieb J, Heinemann V, Ricke J, Peeters M, Findlay M, Weaver A, Mills J, Wilson C, Adams R, Francis A, Moschandreas J, Virdee PS, Dutton P, Love S, Gebski V, Gray A, FOXFIRE trial investigators, SIRFLOX trial investigators, FOXFIRE-Global trial investigators, van Hazel G, Sharma RA) Lancet Oncol 2017 Sep;18(9):1159-1171 328 Citations |
| 2 | Versican-Derived Matrikines Regulate Batf3-Dendritic Cell Differentiation and Promote T Cell Infiltration in Colorectal Cancer. (Hope C, Emmerich PB, Papadas A, Pagenkopf A, Matkowskyj KA, Van De Hey DR, Payne SN, Clipson L, Callander NS, Hematti P, Miyamoto S, Johnson MG, Deming DA, Asimakopoulos F) J Immunol 2017 Sep 01;199(5):1933-1941 94 Citations |
| 1 | Biofunctionalized Hybrid Magnetic Gold Nanoparticles as Catalysts for Photothermal Ablation of Colorectal Liver Metastases. (White SB, Kim DH, Guo Y, Li W, Yang Y, Chen J, Gogineni VR, Larson AC) Radiology 2017 Dec;285(3):809-819 28 Citations |
| 1 | AZD1775 induces toxicity through double-stranded DNA breaks independently of chemotherapeutic agents in p53-mutated colorectal cancer cells. (Webster PJ, Littlejohns AT, Gaunt HJ, Prasad KR, Beech DJ, Burke DA) Cell Cycle 2017;16(22):2176-2182 25 Citations |
| 2 | Housing Discrimination, Residential Racial Segregation, and Colorectal Cancer Survival in Southeastern Wisconsin. (Zhou Y, Bemanian A, Beyer KM) Cancer Epidemiol Biomarkers Prev 2017 Apr;26(4):561-568 77 Citations |
| 1 | Embryonic Origin of Primary Colon Cancer Predicts Pathologic Response and Survival in Patients Undergoing Resection for Colon Cancer Liver Metastases. (Yamashita S, Brudvik KW, Kopetz SE, Maru D, Clarke CN, Passot G, Conrad C, Chun YS, Aloia TA, Vauthey JN) Ann Surg 2018 Mar;267(3):514-520 68 Citations |
| 1 | Trends in gastrointestinal cancer incidence in Iran, 2001-2010: a joinpoint analysis. (Darabi M, Asadi Lari M, Motevalian SA, Motlagh A, Arsang-Jang S, Karimi Jaberi M) Epidemiol Health 2016;38:e2016056 36 Citations |
| 1 | The Use of Robotic and Laparoscopic Surgical Stapling Devices During Minimally Invasive Colon and Rectal Surgery: A Comparison. (Holzmacher JL, Luka S, Aziz M, Amdur RL, Agarwal S, Obias V) J Laparoendosc Adv Surg Tech A 2017 Feb;27(2):151-155 30 Citations |
| 1 | The Impact of Advancing Age on Recurrence and Survival Following Major Hepatectomy for Colorectal Liver Metastases. (Bell R, Pandanaboyana S, Nisar S, Upasani V, Toogood G, Lodge JP, Prasad KR) J Gastrointest Surg 2017 Feb;21(2):266-274 8 Citations |
| 1 | Obesity and colorectal liver metastases: Mechanisms and management. (Pathak S, Pandanaboyana S, Daniels I, Smart N, Prasad KR) Surg Oncol 2016 Sep;25(3):246-51 23 Citations |
| 3 | Achieving low anastomotic leak rates utilizing clinical perfusion assessment. (Kream J, Ludwig KA, Ridolfi TJ, Peterson CY) Surgery 2016 Oct;160(4):960-967 22 Citations |
| 1 | Heat shock protein 70-2 (HSP70-2) is a novel therapeutic target for colorectal cancer and is associated with tumor growth. (Jagadish N, Parashar D, Gupta N, Agarwal S, Suri V, Kumar R, Suri V, Sadasukhi TC, Gupta A, Ansari AS, Lohiya NK, Suri A) BMC Cancer 2016 Jul 29;16:561 54 Citations |
| 1 | Characterization of CC-531 as a Rat Model of Colorectal Liver Metastases. (White SB, Procissi D, Chen J, Gogineni VR, Tyler P, Yang Y, Omary RA, Larson AC) PLoS One 2016;11(5):e0155334 15 Citations |
| 1 | Phase I clinical trial of lenalidomide in combination with bevacizumab in patients with advanced cancer. (Said R, Kakadiaris E, Piha-Paul S, Fu S, Falchook G, Janku F, Wheler JJ, Zinner R, Hong DS, Kurzrock R, Tsimberidou AM) Cancer Chemother Pharmacol 2016 May;77(5):1097-102 5 Citations |
| 4 | Breast and Colorectal Cancer Survival Disparities in Southeastern Wisconsin. (Beyer KM, Zhou Y, Matthews K, Hoormann K, Bemanian A, Laud PW, Nattinger AB) WMJ 2016 Feb;115(1):17-21 21 Citations |
| 1 | Cysteinyl leukotriene 1 receptor influences intestinal polyp incidence in a gender-specific manner in the ApcMin/+ mouse model. (Savari S, Chandrashekar NK, Osman J, Douglas D, Bellamkonda K, Jönsson G, Juhas M, Greicius G, Pettersson S, Sjölander A) Carcinogenesis 2016 May;37(5):491-9 27 Citations |
| 1 | Metastatic Cancer to the Larynx: A Case Report and Update. (Zenga J, Mehrad M, Bradley JP) J Voice 2016 Nov;30(6):774.e9-774.e12 13 Citations |
| 2 | 90Y Radioembolization of Colorectal Hepatic Metastases Using Glass Microspheres: Safety and Survival Outcomes from a 531-Patient Multicenter Study. (Hickey R, Lewandowski RJ, Prudhomme T, Ehrenwald E, Baigorri B, Critchfield J, Kallini J, Gabr A, Gorodetski B, Geschwind JF, Abbott A, Shridhar R, White SB, Rilling WS, Boyer B, Kauffman S, Kwan S, Padia SA, Gates VL, Mulcahy M, Kircher S, Nimeiri H, Benson AB, Salem R) J Nucl Med 2016 May;57(5):665-71 89 Citations |
| 1 | A-kinase anchor protein 4 (AKAP4) a promising therapeutic target of colorectal cancer. (Jagadish N, Parashar D, Gupta N, Agarwal S, Purohit S, Kumar V, Sharma A, Fatima R, Topno AP, Shaha C, Suri A) J Exp Clin Cancer Res 2015 Nov 21;34:142 42 Citations |
| 1 | Retreatment with anti-EGFR based therapies in metastatic colorectal cancer: impact of intervening time interval and prior anti-EGFR response. (Liu X, George GC, Tsimberidou AM, Naing A, Wheler JJ, Kopetz S, Fu S, Piha-Paul SA, Eng C, Falchook GS, Janku F, Garrett C, Karp D, Kurzrock R, Zinner R, Raghav K, Subbiah V, Hess K, Meric-Bernstam F, Hong DS, Overman MJ) BMC Cancer 2015 Oct 16;15:713 45 Citations |
| 1 | Long-term outcomes of an integrated transfusion reduction initiative in patients undergoing resection for colorectal cancer. (Van Osdol AD, Borgert AJ, Kallies KJ, Froman JP, Bottner WA, Shapiro SB) Am J Surg 2015 Dec;210(6):990-4; discussion 995 11 Citations |
| 2 | Comparative Effectiveness of Hepatic Artery Based Therapies for Unresectable Colorectal Liver Metastases: A Meta-Analysis. (Zacharias AJ, Jayakrishnan TT, Rajeev R, Rilling WS, Thomas JP, George B, Johnston FM, Gamblin TC, Turaga KK) PLoS One 2015;10(10):e0139940 47 Citations |
| 1 | Combined BRAF and MEK Inhibition With Dabrafenib and Trametinib in BRAF V600-Mutant Colorectal Cancer. (Corcoran RB, Atreya CE, Falchook GS, Kwak EL, Ryan DP, Bendell JC, Hamid O, Messersmith WA, Daud A, Kurzrock R, Pierobon M, Sun P, Cunningham E, Little S, Orford K, Motwani M, Bai Y, Patel K, Venook AP, Kopetz S) J Clin Oncol 2015 Dec 01;33(34):4023-31 470 Citations |
| 1 | Mice deficient in Muc4 are resistant to experimental colitis and colitis-associated colorectal cancer. (Das S, Rachagani S, Sheinin Y, Smith LM, Gurumurthy CB, Roy HK, Batra SK) Oncogene 2016 May 19;35(20):2645-54 63 Citations |
| 1 | Genetic Variants That Predispose to DNA Double-Strand Breaks in Lymphocytes From a Subset of Patients With Familial Colorectal Carcinomas. (Arora S, Yan H, Cho I, Fan HY, Luo B, Gai X, Bodian DL, Vockley JG, Zhou Y, Handorf EA, Egleston BL, Andrake MD, Nicolas E, Serebriiskii IG, Yen TJ, Hall MJ, Golemis EA, Enders GH) Gastroenterology 2015 Dec;149(7):1872-1883.e9 30 Citations |
| 1 | Synchronous glioblastoma and medulloblastoma in a child with mismatch repair mutation. (Amayiri N, Al-Hussaini M, Swaidan M, Jaradat I, Qandeel M, Tabori U, Hawkins C, Musharbash A, Alsaad K, Bouffet E) Childs Nerv Syst 2016 Mar;32(3):553-7 14 Citations |
| 3 | Perceived Neighborhood Quality and Cancer Screening Behavior: Evidence from the Survey of the Health of Wisconsin. (Beyer KM, Malecki KM, Hoormann KA, Szabo A, Nattinger AB) J Community Health 2016 Feb;41(1):134-7 24 Citations |
| 1 | Enhancing adherence in trials promoting change in diet and physical activity in individuals with a diagnosis of colorectal adenoma; a systematic review of behavioural intervention approaches. (McCahon D, Daley AJ, Jones J, Haslop R, Shajpal A, Taylor A, Wilson S, Dowswell G) BMC Cancer 2015 Jul 07;15:505 14 Citations |
| 1 | Randomized controlled trial of irinotecan drug-eluting beads with simultaneous FOLFOX and bevacizumab for patients with unresectable colorectal liver-limited metastasis. (Martin RC 2nd, Scoggins CR, Schreeder M, Rilling WS, Laing CJ, Tatum CM, Kelly LR, Garcia-Monaco RD, Sharma VR, Crocenzi TS, Strasberg SM) Cancer 2015 Oct 15;121(20):3649-58 132 Citations |
| 1 | Systemic neutrophil-to-lymphocyte ratio in colorectal cancer: the relationship to patient survival, tumour biology and local lymphocytic response to tumour. (Pine JK, Morris E, Hutchins GG, West NP, Jayne DG, Quirke P, Prasad KR) Br J Cancer 2015 Jul 14;113(2):204-11 109 Citations |
| 1 | PD-1 Blockade in Tumors with Mismatch-Repair Deficiency. (Le DT, Uram JN, Wang H, Bartlett BR, Kemberling H, Eyring AD, Skora AD, Luber BS, Azad NS, Laheru D, Biedrzycki B, Donehower RC, Zaheer A, Fisher GA, Crocenzi TS, Lee JJ, Duffy SM, Goldberg RM, de la Chapelle A, Koshiji M, Bhaijee F, Huebner T, Hruban RH, Wood LD, Cuka N, Pardoll DM, Papadopoulos N, Kinzler KW, Zhou S, Cornish TC, Taube JM, Anders RA, Eshleman JR, Vogelstein B, Diaz LA Jr) N Engl J Med 2015 Jun 25;372(26):2509-20 8230 Citations |
| 1 | Association of Perioperative Hypothermia During Colectomy With Surgical Site Infection. (Baucom RB, Phillips SE, Ehrenfeld JM, Muldoon RL, Poulose BK, Herline AJ, Wise PE, Geiger TM) JAMA Surg 2015 Jun;150(6):570-5 48 Citations |
| 1 | Prognostic impact of hyponatraemia in patients with colorectal cancer. (Farid SG, Prasad KR) Colorectal Dis 2015 May;17(5):451 5 Citations |
| 1 | A cost-effective analysis of fibrin sealants versus no sealant following open right hemihepatectomy for colorectal liver metastases. (Pandanaboyana S, Bell R, Shah N, Lodge JPA, Hidalgo E, Toogood GJ, Prasad KR) ANZ J Surg 2017 Jun;87(6):E11-E14 10 Citations |
| 1 | Cost-utility analysis of operative versus non-operative treatment for colorectal liver metastases. (Roberts KJ, Sutton AJ, Prasad KR, Toogood GJ, Lodge JP) Br J Surg 2015 Mar;102(4):388-98 14 Citations |
| 1 | Outcome after liver resection in patients presenting with simultaneous hepatopulmonary colorectal metastases. (Dave RV, Pathak S, White AD, Hidalgo E, Prasad KR, Lodge JP, Milton R, Toogood GJ) Br J Surg 2015 Feb;102(3):261-8 28 Citations |
| 1 | Association between physician time-unlimited vs time-limited internal medicine board certification and ambulatory patient care quality. (Hayes J, Jackson JL, McNutt GM, Hertz BJ, Ryan JJ, Pawlikowski SA) JAMA 2014 Dec 10;312(22):2358-63 45 Citations |
| 1 | Selective Internal Radiation Therapy (SIRT) with yttrium-90 resin microspheres plus standard systemic chemotherapy regimen of FOLFOX versus FOLFOX alone as first-line treatment of non-resectable liver metastases from colorectal cancer: the SIRFLOX study. (Gibbs P, Gebski V, Van Buskirk M, Thurston K, Cade DN, Van Hazel GA, SIRFLOX Study Group) BMC Cancer 2014 Dec 01;14:897 55 Citations |
| 1 | Impact of margin status and neoadjuvant chemotherapy on survival, recurrence after liver resection for colorectal liver metastasis. (Pandanaboyana S, White A, Pathak S, Hidalgo EL, Toogood G, Lodge JP, Prasad KR) Ann Surg Oncol 2015 Jan;22(1):173-9 36 Citations |
| 1 | Relationship between primary colorectal tumour and location of colorectal liver metastases. (Pathak S, Palkhi E, Dave R, White A, Pandanaboyana S, Prasad KR, Lodge JP, Toogood GJ) ANZ J Surg 2016 May;86(5):408-10 6 Citations |
| 1 | Colorectal surgery after kidney transplantation: characteristics of early vs. late posttransplant interventions. (Lee JT, Dunn TB, Sirany AM, Melton GB, Madoff RD, Kwaan MR) J Gastrointest Surg 2014 Jul;18(7):1299-305 11 Citations |
| 1 | Phase 1, open-label, dose-escalation, and pharmacokinetic study of STAT3 inhibitor OPB-31121 in subjects with advanced solid tumors. (Bendell JC, Hong DS, Burris HA 3rd, Naing A, Jones SF, Falchook G, Bricmont P, Elekes A, Rock EP, Kurzrock R) Cancer Chemother Pharmacol 2014 Jul;74(1):125-30 102 Citations |
| 2 | Systematic review of outcomes of patients undergoing resection for colorectal liver metastases in the setting of extra hepatic disease. (Hwang M, Jayakrishnan TT, Green DE, George B, Thomas JP, Groeschl RT, Erickson B, Pappas SG, Gamblin TC, Turaga KK) Eur J Cancer 2014 Jul;50(10):1747-1757 79 Citations |
| 1 | O-GlcNAcylation stabilizes β-catenin through direct competition with phosphorylation at threonine 41. (Olivier-Van Stichelen S, Dehennaut V, Buzy A, Zachayus JL, Guinez C, Mir AM, El Yazidi-Belkoura I, Copin MC, Boureme D, Loyaux D, Ferrara P, Lefebvre T) FASEB J 2014 Aug;28(8):3325-38 133 Citations |
| 1 | Transarterial treatment of colorectal cancer liver metastases with irinotecan-loaded drug-eluting beads: technical recommendations. (Lencioni R, Aliberti C, de Baere T, Garcia-Monaco R, Narayanan G, O'Grady E, Rilling WS, Walker D, Martin RC) J Vasc Interv Radiol 2014 Mar;25(3):365-9 53 Citations |
| 1 | Achieving a complete colonic evaluation in patients with incomplete colonoscopy is worth the effort. (Ridolfi TJ, Valente MA, Church JM) Dis Colon Rectum 2014 Mar;57(3):383-7 21 Citations |
| 1 | Assessing PIK3CA and PTEN in early-phase trials with PI3K/AKT/mTOR inhibitors. (Janku F, Hong DS, Fu S, Piha-Paul SA, Naing A, Falchook GS, Tsimberidou AM, Stepanek VM, Moulder SL, Lee JJ, Luthra R, Zinner RG, Broaddus RR, Wheler JJ, Kurzrock R) Cell Rep 2014 Jan 30;6(2):377-87 214 Citations |
| 1 | Nodular regenerative hyperplasia (NRH) complicating oxaliplatin chemotherapy in patients undergoing resection of colorectal liver metastases. (Morris-Stiff G, White AD, Gomez D, Cameron IC, Farid S, Toogood GJ, Lodge JP, Prasad KR) Eur J Surg Oncol 2014 Aug;40(8):1016-20 35 Citations |
| 1 | Variation in referral practice for patients with colorectal cancer liver metastases. (Young AL, Adair R, Culverwell A, Guthrie JA, Botterill ID, Toogood GJ, Lodge JP, Prasad KR) Br J Surg 2013 Nov;100(12):1627-32 32 Citations |
| 1 | The Vulnerable Elders Survey-13 predicts mortality in older adults with later-stage colorectal cancer receiving chemotherapy: a prospective pilot study. (Ramsdale E, Polite B, Hemmerich J, Bylow K, Kindler HL, Mohile S, Dale W) J Am Geriatr Soc 2013 Nov;61(11):2043-4 14 Citations |
| 1 | The prevalence of laparoscopy and patient safety outcomes: an analysis of colorectal resections. (Peterson CY, Palazzi K, Parsons JK, Chang DC, Ramamoorthy SL) Surg Endosc 2014 Feb;28(2):608-16 16 Citations |
| 1 | Target-based therapeutic matching in early-phase clinical trials in patients with advanced colorectal cancer and PIK3CA mutations. (Ganesan P, Janku F, Naing A, Hong DS, Tsimberidou AM, Falchook GS, Wheler JJ, Piha-Paul SA, Fu S, Stepanek VM, Lee JJ, Luthra R, Overman MJ, Kopetz ES, Wolff RA, Kurzrock R) Mol Cancer Ther 2013 Dec;12(12):2857-63 42 Citations |
| 1 | Repeat liver resection after a hepatic or extended hepatic trisectionectomy for colorectal liver metastasis. (Ziff O, Rajput I, Adair R, Toogood GJ, Prasad KR, Lodge JP) HPB (Oxford) 2014 Mar;16(3):212-9 8 Citations |
| 1 | Repeat liver resection for recurrent colorectal metastases: a single-centre, 13-year experience. (Battula N, Tsapralis D, Mayer D, Isaac J, Muiesan P, Sutcliffe RP, Bramhall S, Mirza D, Marudanayagam R) HPB (Oxford) 2014 Feb;16(2):157-63 53 Citations |
| 1 | Bevacizumab-based treatment in colorectal cancer with a NRAS Q61K mutation. (Janku F, Wheler JJ, Hong DS, Kurzrock R) Target Oncol 2013 Sep;8(3):183-188 7 Citations |
| 1 | Endoscopic mis-sizing of polyps changes colorectal cancer surveillance recommendations. (Eichenseer PJ, Dhanekula R, Jakate S, Mobarhan S, Melson JE) Dis Colon Rectum 2013 Mar;56(3):315-21 68 Citations |
| 1 | Fatty liver disease as a predictor of local recurrence following resection of colorectal liver metastases. (Hamady ZZ, Rees M, Welsh FK, Toogood GJ, Prasad KR, John TK, Lodge JP) Br J Surg 2013 May;100(6):820-6 59 Citations |
| 1 | PDCD4/miR-21 dysregulation in inflammatory bowel disease-associated carcinogenesis. (Ludwig K, Fassan M, Mescoli C, Pizzi M, Balistreri M, Albertoni L, Pucciarelli S, Scarpa M, Sturniolo GC, Angriman I, Rugge M) Virchows Arch 2013 Jan;462(1):57-63 60 Citations |
| 1 | The impact of an integrated transfusion reduction initiative in patients undergoing resection for colorectal cancer. (Froman JP, Mathiason MA, Kallies KJ, Bottner WA, Shapiro SB) Am J Surg 2012 Dec;204(6):944-50; discussion 950-1 25 Citations |
| 1 | Phase I study of the antiangiogenic antibody bevacizumab and the mTOR/hypoxia-inducible factor inhibitor temsirolimus combined with liposomal doxorubicin: tolerance and biological activity. (Moroney J, Fu S, Moulder S, Falchook G, Helgason T, Levenback C, Hong D, Naing A, Wheler J, Kurzrock R) Clin Cancer Res 2012 Oct 15;18(20):5796-805 79 Citations |
| 1 | Repeat hepatic resection for colorectal liver metastases. (Adair RA, Young AL, Cockbain AJ, Malde D, Prasad KR, Lodge JP, Toogood GJ) Br J Surg 2012 Sep;99(9):1278-83 55 Citations |
| 1 | KRASness and PIK3CAness in patients with advanced colorectal cancer: outcome after treatment with early-phase trials with targeted pathway inhibitors. (Garrido-Laguna I, Hong DS, Janku F, Nguyen LM, Falchook GS, Fu S, Wheler JJ, Luthra R, Naing A, Wang X, Kurzrock R) PLoS One 2012;7(5):e38033 50 Citations |
| 1 | A phase I first-in-human trial of bardoxolone methyl in patients with advanced solid tumors and lymphomas. (Hong DS, Kurzrock R, Supko JG, He X, Naing A, Wheler J, Lawrence D, Eder JP, Meyer CJ, Ferguson DA, Mier J, Konopleva M, Konoplev S, Andreeff M, Kufe D, Lazarus H, Shapiro GI, Dezube BJ) Clin Cancer Res 2012 Jun 15;18(12):3396-406 217 Citations |
| 1 | Outcomes in 144 patients with colorectal cancer treated in a phase I clinic: the MD Anderson Cancer Center experience. (Hong DS, Patel JC, Wheler J, Naing A, Garrido-Laguna I, Falchook G, Fu S, Tsimberidou AM, Kopetz S, Win S, Kurzrock R) Clin Colorectal Cancer 2012 Dec;11(4):297-303 9 Citations |
| 1 | BRAF(V600) inhibitor GSK2118436 targeted inhibition of mutant BRAF in cancer patients does not impair overall immune competency. (Hong DS, Vence L, Falchook G, Radvanyi LG, Liu C, Goodman V, Legos JJ, Blackman S, Scarmadio A, Kurzrock R, Lizee G, Hwu P) Clin Cancer Res 2012 Apr 15;18(8):2326-35 96 Citations |
| 1 | Synchronous resection of colorectal cancer and liver metastases: comparative views of colorectal and liver surgeons. (Qureshi MS, Goldsmith PJ, Maslekar S, Prasad KR, Botterill ID) Colorectal Dis 2012 Aug;14(8):e477-85 14 Citations |
| 1 | Role of quantification of hepatic steatosis and future remnant volume in predicting hepatic dysfunction and complications after liver resection for colorectal metastases: a pilot study. (Young AL, Wilson D, Ward J, Biglands J, Guthrie JA, Prasad KR, Toogood GJ, Robinson PJ, Lodge JP) HPB (Oxford) 2012 Mar;14(3):194-200 5 Citations |
| 1 | The hexosamine biosynthetic pathway and O-GlcNAcylation drive the expression of β-catenin and cell proliferation. (Olivier-Van Stichelen S, Guinez C, Mir AM, Perez-Cervera Y, Liu C, Michalski JC, Lefebvre T) Am J Physiol Endocrinol Metab 2012 Feb 15;302(4):E417-24 64 Citations |
| 1 | Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. (Kostic AD, Gevers D, Pedamallu CS, Michaud M, Duke F, Earl AM, Ojesina AI, Jung J, Bass AJ, Tabernero J, Baselga J, Liu C, Shivdasani RA, Ogino S, Birren BW, Huttenhower C, Garrett WS, Meyerson M) Genome Res 2012 Feb;22(2):292-8 1680 Citations |
| 2 | Monomeric and dimeric CXCL12 inhibit metastasis through distinct CXCR4 interactions and signaling pathways. (Drury LJ, Ziarek JJ, Gravel S, Veldkamp CT, Takekoshi T, Hwang ST, Heveker N, Volkman BF, Dwinell MB) Proc Natl Acad Sci U S A 2011 Oct 25;108(43):17655-60 190 Citations |
| 1 | [Signaling and metabolic predispositions linked to the colorectal cancer]. (Olivier S, Mir AM, Michalski JC, Lefebvre T) Med Sci (Paris) 2011 May;27(5):514-20 2 Citations |
| 1 | The challenge in treating the elderly colorectal cancer patient. (Ludwig KA) Ann Surg Oncol 2011 Jun;18(6):1520-1 |
| 1 | Exploratory study of hepatic arterial infusion oxaliplatin with systemic 5-fluorouracil/bevacizumab in patients with refractory solid tumor and extensive liver metastases. (Camacho LH, Garcia S, Panchal AM, Lim J, Hong DS, Ng C, Madoff DC, Fu S, Gayed I, Kurzrock R) Clin Colorectal Cancer 2010 Dec;9(5):311-4 10 Citations |
| 1 | Explaining place-based colorectal cancer health disparities: evidence from a rural context. (Beyer KM, Comstock S, Seagren R, Rushton G) Soc Sci Med 2011 Feb;72(3):373-82 32 Citations |
| 1 | A first-in-human study of conatumumab in adult patients with advanced solid tumors. (Herbst RS, Kurzrock R, Hong DS, Valdivieso M, Hsu CP, Goyal L, Juan G, Hwang YC, Wong S, Hill JS, Friberg G, LoRusso PM) Clin Cancer Res 2010 Dec 01;16(23):5883-91 125 Citations |
| 1 | CXCL12 chemokine expression and secretion regulates colorectal carcinoma cell anoikis through Bim-mediated intrinsic apoptosis. (Drury LJ, Wendt MK, Dwinell MB) PLoS One 2010 Sep 22;5(9):e12895 42 Citations |
| 1 | Portal vein ligation accelerates tumor growth in ligated, but not contralateral lobes. (Sakai N, Clarke CN, Schuster R, Blanchard J, Tevar AD, Edwards MJ, Lentsch AB) World J Gastroenterol 2010 Aug 14;16(30):3816-26 12 Citations |
| 1 | Higher physician density is associated with lower incidence of late-stage colorectal cancer. (Ananthakrishnan AN, Hoffmann RG, Saeian K) J Gen Intern Med 2010 Nov;25(11):1164-71 71 Citations |
| 1 | A phase II study of oxaliplatin, 5-fluorouracil, leucovorin, and high-dose capecitabine in patients with metastatic colorectal cancer. (Lubner SJ, Loconte NK, Holen KD, Schelman W, Thomas JP, Jumonville A, Eickhoff JC, Seo S, Mulkerin DL) Clin Colorectal Cancer 2010 Jul;9(3):157-61 8 Citations |
| 1 | Outcomes of intensive surveillance after resection of hepatic colorectal metastases. (Gomez D, Sangha VK, Morris-Stiff G, Malik HZ, Guthrie AJ, Toogood GJ, Lodge JP, Prasad KR) Br J Surg 2010 Oct;97(10):1552-60 43 Citations |
| 2 | The relationship of health numeracy to cancer screening. (Schapira MM, Neuner J, Fletcher KE, Gilligan MA, Hayes E, Laud P) J Cancer Educ 2011 Mar;26(1):103-10 17 Citations |
| 1 | Interaction of tumour biology and tumour burden in determining outcome after hepatic resection for colorectal metastases. (Gomez D, Morris-Stiff G, Toogood GJ, Lodge JP, Prasad KR) HPB (Oxford) 2010 Mar;12(2):84-93 18 Citations |
| 1 | When to stop screening: a review of breast, gynecologic, and colorectal cancer screening in women over age 65. (Bernstein R, DeJoseph D, Buchanan EM) Care Manag J 2010;11(1):48-57 6 Citations |
| 1 | Chemotherapy resistance and retreatment: a dogma revisited. (Naing A, Kurzrock R) Clin Colorectal Cancer 2010 Apr;9(2):E1-4 |
| 1 | Disease maps as context for community mapping: a methodological approach for linking confidential health information with local geographical knowledge for community health research. (Beyer KM, Comstock S, Seagren R) J Community Health 2010 Dec;35(6):635-44 22 Citations |
| 2 | Hypersensitivity reaction and acute immune-mediated thrombocytopenia from oxaliplatin: two case reports and a review of the literature. (Bautista MA, Stevens WT, Chen CS, Curtis BR, Aster RH, Hsueh CT) J Hematol Oncol 2010 Mar 26;3:12 62 Citations |
| 1 | Chemoprevention of colorectal cancer by targeting APC-deficient cells for apoptosis. (Zhang L, Ren X, Alt E, Bai X, Huang S, Xu Z, Lynch PM, Moyer MP, Wen XF, Wu X) Nature 2010 Apr 15;464(7291):1058-61 128 Citations |
| 1 | Correlation between postoperative infective complications and long-term outcomes after hepatic resection for colorectal liver metastasis. (Farid SG, Aldouri A, Morris-Stiff G, Khan AZ, Toogood GJ, Lodge JP, Prasad KR) Ann Surg 2010 Jan;251(1):91-100 191 Citations |
| 1 | Oxaliplatin-induced immune thrombocytopenia: another cumulative dose-dependent side effect? (James E, Podoltsev N, Salehi E, Curtis BR, Saif MW) Clin Colorectal Cancer 2009 Oct;8(4):220-4 28 Citations |
| 1 | Mapping cancer for community engagement. (Beyer KM, Rushton G) Prev Chronic Dis 2009 Jan;6(1):A03 42 Citations |
| 1 | Informed decision-making and colorectal cancer screening: is it occurring in primary care? (Ling BS, Trauth JM, Fine MJ, Mor MK, Resnick A, Braddock CH, Bereknyei S, Weissfeld JL, Schoen RE, Ricci EM, Whittle J) Med Care 2008 Sep;46(9 Suppl 1):S23-9 67 Citations |
| 1 | The impact of caudate lobe involvement after hepatic resection for colorectal metastases. (Khan AZ, Wong VK, Malik HZ, Stiff GM, Prasad KR, Lodge JP, Toogood GJ) Eur J Surg Oncol 2009 May;35(5):510-4 8 Citations |
| 1 | Surgical technique and systemic inflammation influences long-term disease-free survival following hepatic resection for colorectal metastasis. (Gomez D, Morris-Stiff G, Wyatt J, Toogood GJ, Lodge JP, Prasad KR) J Surg Oncol 2008 Oct 01;98(5):371-6 58 Citations |
| 1 | Constitutive CXCL12 expression induces anoikis in colorectal carcinoma cells. (Wendt MK, Drury LJ, Vongsa RA, Dwinell MB) Gastroenterology 2008 Aug;135(2):508-17 46 Citations |
| 1 | Chemokines and chemokine receptors in mucosal homeostasis at the intestinal epithelial barrier in inflammatory bowel disease. (Zimmerman NP, Vongsa RA, Wendt MK, Dwinell MB) Inflamm Bowel Dis 2008 Jul;14(7):1000-11 138 Citations |
| 1 | C-reactive protein in liver cancer surgery. (Morris-Stiff G, Gomez D, Prasad KR) Eur J Surg Oncol 2008 Jul;34(7):727-9 76 Citations |
| 1 | Surgeon's awareness of the synchronous liver metastases during colorectal cancer resection may affect outcome. (Hamady ZZ, Malik HZ, Alwan N, Wyatt JI, Prasad KR, Toogood GJ, Lodge JP) Eur J Surg Oncol 2008 Feb;34(2):180-4 6 Citations |
| 1 | Preoperative prognostic score for predicting survival after hepatic resection for colorectal liver metastases. (Malik HZ, Prasad KR, Halazun KJ, Aldoori A, Al-Mukhtar A, Gomez D, Lodge JP, Toogood GJ) Ann Surg 2007 Nov;246(5):806-14 187 Citations |
| 1 | A critical appraisal of the role of neoadjuvant chemotherapy for colorectal liver metastases: a case-controlled study. (Malik HZ, Farid S, Al-Mukthar A, Anthoney A, Toogood GJ, Lodge JP, Prasad KR) Ann Surg Oncol 2007 Dec;14(12):3519-26 26 Citations |
| 1 | Simultaneous resections of colorectal cancer and synchronous liver metastases: a multi-institutional analysis. (Reddy SK, Pawlik TM, Zorzi D, Gleisner AL, Ribero D, Assumpcao L, Barbas AS, Abdalla EK, Choti MA, Vauthey JN, Ludwig KA, Mantyh CR, Morse MA, Clary BM) Ann Surg Oncol 2007 Dec;14(12):3481-91 371 Citations |
| 1 | Effect of type of resection on outcome of hepatic resection for colorectal metastases. (Finch RJ, Malik HZ, Hamady ZZ, Al-Mukhtar A, Adair R, Prasad KR, Lodge JP, Toogood GJ) Br J Surg 2007 Oct;94(10):1242-8 72 Citations |
| 1 | Steatosis predicts postoperative morbidity following hepatic resection for colorectal metastasis. (Gomez D, Malik HZ, Bonney GK, Wong V, Toogood GJ, Lodge JP, Prasad KR) Br J Surg 2007 Nov;94(11):1395-402 121 Citations |
| 2 | Colorectal cancer screening among midwestern community-based residents: indicators of success. (Matthews BA, Nattinger AB, Venkatesan T, Shaker R) J Community Health 2007 Apr;32(2):103-20 9 Citations |
| 1 | Biological characteristics and behaviour of putatively curatively resected colorectal liver metastases. (Rajaganeshan R, Jayne DG, Malik HZ, Scott N, Lodge JP, Toogood GJ, Prasad KR) Eur J Surg Oncol 2008 Apr;34(4):439-44 3 Citations |
| 1 | Elevated preoperative neutrophil to lymphocyte ratio predicts survival following hepatic resection for colorectal liver metastases. (Halazun KJ, Aldoori A, Malik HZ, Al-Mukhtar A, Prasad KR, Toogood GJ, Lodge JP) Eur J Surg Oncol 2008 Jan;34(1):55-60 393 Citations |
| 1 | Liposomal curcumin with and without oxaliplatin: effects on cell growth, apoptosis, and angiogenesis in colorectal cancer. (Li L, Ahmed B, Mehta K, Kurzrock R) Mol Cancer Ther 2007 Apr;6(4):1276-82 336 Citations |
| 2 | Objective risk, subjective risk, and colorectal cancer screening among a clinic sample. (Matthews BA, Nattinger AB, Venkatesan T, Shaker R, Anderson RC) Psychol Health Med 2007 Mar;12(2):135-47 4 Citations |
| 1 | Predictors of early disease recurrence following hepatic resection for colorectal cancer metastasis. (Malik HZ, Gomez D, Wong V, Al-Mukthar A, Toogood GJ, Lodge JP, Prasad KR) Eur J Surg Oncol 2007 Oct;33(8):1003-9 65 Citations |
| 1 | C-reactive protein as a predictor of prognosis following curative resection for colorectal liver metastases. (Wong VK, Malik HZ, Hamady ZZ, Al-Mukhtar A, Gomez D, Prasad KR, Toogood GJ, Lodge JP) Br J Cancer 2007 Jan 29;96(2):222-5 98 Citations |
| 1 | Novel in vivo imaging shows up-regulation of death receptors by paclitaxel and correlates with enhanced antitumor effects of receptor agonist antibodies. (Gong J, Yang D, Kohanim S, Humphreys R, Broemeling L, Kurzrock R) Mol Cancer Ther 2006 Dec;5(12):2991-3000 33 Citations |
| 1 | Prognostic influence of multiple hepatic metastases from colorectal cancer. (Malik HZ, Hamady ZZ, Adair R, Finch R, Al-Mukhtar A, Toogood GJ, Prasad KR, Lodge JP) Eur J Surg Oncol 2007 May;33(4):468-73 56 Citations |
| 1 | Hepatic resection for colorectal metastasis: impact of tumour size. (Hamady ZZ, Malik HZ, Finch R, Adair R, Al-Mukhtar A, Prasad KR, Toogood GJ, Lodge JP) Ann Surg Oncol 2006 Nov;13(11):1493-9 25 Citations |
| 1 | Colorectal Cancer Screening Clinical Practice Guidelines. (Levin B, Barthel JS, Burt RW, David DS, Ford JM, Giardiello FM, Gruber SB, Halverson AL, Hamilton S, Kohlmann W, Ludwig KA, Lynch PM, Marino C, Martin EW Jr, Mayer RJ, Pasche B, Pirruccello SJ, Rajput A, Rao MS, Shike M, Steinbach G, Terdiman JP, Weinberg D, Winawer SJ) J Natl Compr Canc Netw 2006 Apr;4(4):384-420 35 Citations |
| 1 | Silencing of epithelial CXCL12 expression by DNA hypermethylation promotes colonic carcinoma metastasis. (Wendt MK, Johanesen PA, Kang-Decker N, Binion DG, Shah V, Dwinell MB) Oncogene 2006 Aug 17;25(36):4986-97 133 Citations |
| 1 | Colorectal cancer screening behavior and health insurance status (United States). (Matthews BA, Anderson RC, Nattinger AB) Cancer Causes Control 2005 Aug;16(6):735-42 62 Citations |
| 1 | Left hepatic trisectionectomy for hepatobiliary malignancy: results and an appraisal of its current role. (Nishio H, Hidalgo E, Hamady ZZ, Ravindra KV, Kotru A, Dasgupta D, Al-Mukhtar A, Prasad KR, Toogood GJ, Lodge JP) Ann Surg 2005 Aug;242(2):267-75 73 Citations |
| 1 | Neuroendocrine hepatic metastases: does aggressive management improve survival? (Touzios JG, Kiely JM, Pitt SC, Rilling WS, Quebbeman EJ, Wilson SD, Pitt HA) Ann Surg 2005 May;241(5):776-83; discussion 783-5 318 Citations |
| 1 | Meta-analysis: computed tomographic colonography. (Mulhall BP, Veerappan GR, Jackson JL) Ann Intern Med 2005 Apr 19;142(8):635-50 324 Citations |
| 1 | Prolonging the return visit interval in primary care. (Schectman G, Barnas G, Laud P, Cantwell L, Horton M, Zarling EJ) Am J Med 2005 Apr;118(4):393-9 29 Citations |
| 1 | In-contiguity and non-anatomical extension of right hepatic trisectionectomy for liver metastases. (Lodge JP, Menon KV, Fenwick SW, Prasad KR, Toogood GJ) Br J Surg 2005 Mar;92(3):340-7 17 Citations |
| 1 | Hepatic arterial infusion chemotherapy for metastatic colorectal cancer: a concise overview. (Barber FD, Mavligit G, Kurzrock R) Cancer Treat Rev 2004 Aug;30(5):425-36 41 Citations |
| 1 | Postmenopausal hormone therapy: a concise guide to therapeutic uses, formulations, risks, and alternatives. (Mitchell JL, Walsh J, Wang-Cheng R, Hardman JL) Prim Care 2003 Dec;30(4):671-96 3 Citations |
| 1 | Role of neoadjuvant chemotherapy in the treatment of multiple colorectal metastases to the liver (Br J Surg 2003; 90: 963-969). (Rahman S, Toogood GJ, Lodge PJ, Prasad KR) Br J Surg 2003 Nov;90(11):1453 4 Citations |
| 1 | Phase II trial of perillyl alcohol in patients with metastatic colorectal cancer. (Meadows SM, Mulkerin D, Berlin J, Bailey H, Kolesar J, Warren D, Thomas JP) Int J Gastrointest Cancer 2002;32(2-3):125-8 67 Citations |
| 1 | Colorectal cancer screening. Clinical practice guidelines in oncology. (Levin B, Ludwig KA, Steinbach G, National Comprehensive Cancer Network) J Natl Compr Canc Netw 2003 Jan;1(1):72-93 8 Citations |
| 1 | MSI in endometrial carcinoma: absence of MLH1 promoter methylation is associated with increased familial risk for cancers. (Whelan AJ, Babb S, Mutch DG, Rader J, Herzog TJ, Todd C, Ivanovich JL, Goodfellow PJ) Int J Cancer 2002 Jun 10;99(5):697-704 36 Citations |
| 1 | [Expression of p21 WAF1/CIP1 protein in colorectal cancers: study of its relation to p53 mutation and Ki67 antigen expression]. (Chapusot C, Assem M, Martin L, Chalabreyssse L, Benhamiche AM, Lignier MA, Chauffert B, Teyssier JR, Faivre J, Piard F) Pathol Biol (Paris) 2001 Mar;49(2):115-23 2 Citations |
| 1 | Ablation of liver metastasis: is preoperative imaging sufficiently accurate? (Wallace JR, Christians KK, Quiroz FA, Foley WD, Pitt HA, Quebbeman EJ) J Gastrointest Surg 2001;5(1):98-107 34 Citations |
| 1 | Management of women at risk for malignancy. (Basil JB, Rader JS) Curr Opin Oncol 2000 Sep;12(5):508-13 1 Citation |
| 1 | Are there several types of colorectal carcinomas? Correlations with genetic data. (Martin L, Assem M, Piard F) Eur J Cancer Prev 1999 Dec;8 Suppl 1:S13-20 20 Citations |
| 1 | Ex vivo and in situ resection of inferior vena cava with hepatectomy for colorectal metastases. (Lodge JP, Ammori BJ, Prasad KR, Bellamy MC) Ann Surg 2000 Apr;231(4):471-9 145 Citations |
| 1 | Atypical clustering of gynecologic malignancies: A family study including molecular analysis of candidate genes. (Cohn DE, Babb S, Whelan AJ, Mutch DG, Herzog TJ, Rader JS, Elbendary A, Goodfellow PJ) Gynecol Oncol 2000 Apr;77(1):18-25 9 Citations |
| 1 | Cryotherapy extends the indications for treatment of colorectal liver metastases. (Wallace JR, Christians KK, Pitt HA, Quebbeman EJ) Surgery 1999 Oct;126(4):766-72; discussion 772-4 59 Citations |
| 1 | Epidermal growth factor receptor expression in primary cultured human colorectal carcinoma cells. (Tong WM, Ellinger A, Sheinin Y, Cross HS) Br J Cancer 1998 Jun;77(11):1792-8 52 Citations |
| 1 | Perioperative tumor localization for laparoscopic colorectal surgery. (Kim SH, Milsom JW, Church JM, Ludwig KA, Garcia-Ruiz A, Okuda J, Fazio VW) Surg Endosc 1997 Oct;11(10):1013-6 99 Citations |
| 2 | Surgical management of colorectal metastases to the liver: role of resection and cryosurgery. (Redlich PN, Baker EJ, McAuliffe TL, Quebbeman EJ) Wis Med J 1996 Dec;95(12):859-63 6 Citations |
| 1 | Association of gastric adenocarcinoma with the HLA class II gene DQB10301. (Lee JE, Lowy AM, Thompson WA, Lu M, Loflin PT, Skibber JM, Evans DB, Curley SA, Mansfield PF, Reveille JD) Gastroenterology 1996 Aug;111(2):426-32 80 Citations |
| 1 | Muir-Torre syndrome. (Cohen PR, Kohn SR, Davis DA, Kurzrock R) Dermatol Clin 1995 Jan;13(1):79-89 92 Citations |
| 1 | Association of sebaceous gland tumors and internal malignancy: the Muir-Torre syndrome. (Cohen PR, Kohn SR, Kurzrock R) Am J Med 1991 May;90(5):606-13 278 Citations |
